New Delhi: Shares of Sun Pharma came under massive selling Friday, tumbling over 13 percent, amid reports of fresh allegations by a whistleblower against the company.
The scrip after a weak opening further tumbled 12.11 percent to hit a multi-year low of Rs 375.40 on BSE.
At NSE, shares of the company plummeted 13.21 percent to hit a low of Rs 370.20.
The stock was the worst hit among the blue chips on both the key indices during the morning trading session.
In terms of equity volume, 38.20 lakh shares of the company were traded on BSE and over 4 crore shares changed hands at NSE during the day.
According to reports, the complaint, sent to the capital market regulator SEBI, is the second in over a month.
Meanwhile, the BSE has sought clarification from Sun Pharmaceutical Industries on January 18, 2019, with reference to news that Sun Pharma plummets over buzz of fresh whistleblower complaint.
A whistleblower had in November last year approached Sebi with a document alleging various irregularities by the company, its promoter and others.
To keep watching India’s No. 1 English Business News Channel – CNBC-TV18, call your Cable or DTH Operator and ask for the Colors Family Pack (inclusive of 24 channels), available for Rs. 35/- per month, or subscribe to the channel for Rs. 4/- per day.
To keep watching the Leader in Global Market & Business News – CNBC-TV18 Prime HD, call your Cable or DTH Operator and ask for the Colors Family HD Pack (inclusive of 25 channels), available for Rs. 50/- per month, or subscribe to the channel for Rs. 1/- per day.
Updated Date: Jan 18, 2019 14:33:49 IST